Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|September 20, 2011
Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its sheddingSonia Agüera-González, Catharina C Gross, Lola Fernández-Messina, et al.
Scientific Reports|June 7, 2024
BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectorsMaría-José Felgueres, Gloria Esteso, Álvaro F García-Jiménez, et al.
Oncoimmunology|May 17, 2017
Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytesEva M García-Cuesta, Gloria Esteso, Omodele Ashiru, et al.
NPJ Vaccines|March 29, 2025
Cytolytic γδ T-cells and IFNγ-producing CD4-lymphocytes characterise the early response to MTBVAC tuberculosis vaccineMaría-José Felgueres, Gloria Esteso, Álvaro F García-Jiménez, et al.
Oncoimmunology|December 26, 2022
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitroGloria Esteso, María José Felgueres, Álvaro F García-Jiménez, et al.
Cancers|July 7, 2019
BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient UrineOmodele Ashiru, Gloria Esteso, Eva M García-Cuesta, et al.
BMC Research Notes|July 2, 2011
Characterisation of five candidate genes within the ETEC F4ab/ac candidate region in pigsMette Jacobsen, Susanna Cirera, David Joller, et al.
Frontiers in Immunology|June 25, 2015
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell ActivationEva María García-Cuesta, Sheila López-Cobo, Mario Álvarez-Maestro, et al.
Frontiers in Immunology|October 3, 2022
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patientsEva Castellano, Célia Samba, Gloria Esteso, et al.
Nature Communications|October 4, 2023
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungEduardo Moreo, Aitor Jarit-Cabanillas, Iñaki Robles-Vera, et al.
Pageof 3